ABSTRACT. Thioacetamide (TA) is a potent hepatotoxicant known to affect liver metabolism, inhibit mRNA transport and induce immune suppression. The genetic mechanism underlining this biological toxic compound is well understood using microarray technology. Thus, we used high-throughput rat genome oligonucleotide microarrays containing approximately 22,000 genes to investigate the genetic components of TA-related cytotoxicity in WB-F344 rat liver epithelial (WB-F344) cells. We treated cells with TA (two concentrations over five time periods, ranging from 1 to 24 hr), isolated total RNA at 1, 3, 6, 12 and 24 hr following TA treatment and hybridized the RNA to microarrays. Clustering analysis distinguished two groups of genes, early (1 and 3 hr) and late (6, 12 and 24 hr) phase genes. In total, 2,129 and 2,348 differentially-expressed genes were identified following treatment with low and high concentrations of TA, respectively. A common set of 1,229 genes that were differentially expressed following treatment with both low (1,000 M) and high (10,000 M) concentrations of TA had similar expression patterns. Interestingly, 1,410 genes at the low concentration and 1,858 genes at the high concentration were differentially expressed in the early phases, suggesting that these genes associated with the early response to TA may be useful as early markers of hepatotoxicity.
Toxicogenomics describes the measurement of global gene expression changes in biological samples following exposure to toxicants [6, 14] . Comparison of two or more toxicants with similar cytotoxicity using DNA microarrays is an extremely powerful method by which gene expression of toxic effects can be analyzed [9-11, 17, 18, 22] . Therefore, many pharmaceutical companies and research groups are generating toxicogenomic databases containing gene expression profiles related to the molecular mechanism behind a compound's toxicity [4, 21, 35] . These databases serve as gene expression signatures for several well-characterized toxic compounds; this information is also used as a baseline for future toxicogenomic studies [16, 23] .
The liver is one of the first detoxifying organs to be exposed to chemicals administered perorally or through the portal vein. The liver is also the major site for metabolizing xenobiotics, and this process can in turn form active metabolites. Thus, the liver is a primary target for various types of chemically-induced toxicity. During interpretation of toxicogenomic data, it is challenging to unravel how chemically-induced changes in gene expression are related to conventional toxicological endpoints [2, 7, 27, 29] . Therefore, we designed this study to investigate the changed in gene expression associated with liver toxicity and to determine whether specific expression profiles correlate to the extent of liver toxicity. Establishing such patterns in an in vitro model system could be useful for assessing liver toxicity.
We chose TA as a model hepatotoxicant for this study. TA induces liver necrosis, subsequent cirrhosis and hepatocellular carcinoma in animal model studies [1] . Within the nucleus, TA enlarges the nucleoli and promotes accumulation of RNA [32] . It also increase the amount and specific activity of total mRNA and disproportionately increases the amount of albumin mRNA in hepatocytes [3, 5] .
WB-F344 cells are the best characterized non-tumorigenic diploid epithelial cells isolated from the liver of the adult male Fischer-344 rat [34] . The phenotypic properties of liver epithelial cells in vitro more closely resemble those of oval cells because WB-F344 cells can exhibit phenotypic characteristics of both hepatocytes and cholangiocytes (bile duct epithelial cells) compared with normal hepatocytes, biliary epithelial (ductular) and oval cells isolated from livers treated with chemical carcinogens [34] . Oval cells, or liver stem cells, function as a regenerative reservoir in acute liver damage [30] and may play a role in the formation of liver tumors in rodents and humans [8] . We used OpArray Rat genome 27K oligonucleotide microarrays to investigate whether the toxic effects of TA promote differential expression profiles in WB-F344 cells. In the early phases of hepatocyte cytotoxicity, TA induced differential expression of 1,407 and 1,858 genes at low and high concentrations, respectively. To better define expression profiles that may be early predictors of TA-induced toxicity, we administered two different concentrations of TA to WB-F344 cells for five time periods ranging from 1 to 24 hr and compared the amounts of gene expression. In addition, we also confirmed the altered expression of several genes using real-time polymerase chain reaction analysis.
MATERIALS AND METHODS
Cell culture: The WB-F344 cells, a kind gift from Dr J. Trosko of Michigan State University (East Lansing, MI, U.S.A.), were cultured in D-media (Formula No. 78-5470EF, Gibco BRL, Grand Island, NY, U.S.A.) supplemented with 3 ml/l penicillin-streptomycin-neomycin solution (Gibco BRL) and 5% fetal bovine serum (Gibco BRL). The cells were maintained in a 37C humidified incubator containing 5% CO 2 . They were subsequently passaged in 175 cm 2 flasks (Nunc; Paisley, UK), and their culture medium was changed every other day.
Cell viability assay: The cytotoxic effects of TA (CAS # 62-55-5, Sigma-Aldrich, St. Louis, MO, U.S.A.) in WB-F344 cells were measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (a tetrazole; MTT) assay, which is based on the ability of live cells to convert a tetrazolium salt into purple formazan. The absorbency at 570 nm was measured with an EL800 microplate reader (BIO-TEK Instruments, Winooski, VT, U.S.A.).
RNA isolation: WB-F344 cells were placed in 100-mm tissue culture dishes at a density of 2 10 5 cells/ml and then subjected to TA exposure for 1, 3, 6, 12 or 24 hr. Following incubation, the WB-F344 cells were washed three times in PBS and scraped into 1 ml TRIzol Reagent TM (Invitrogen, Carlsbad, CA, U.S.A.) per dish. RNA was extracted from four individual cultures, and equal amounts of RNA from each culture were pooled. Total RNA was extracted according to the manufacturer's instructions and quantified by spectrophotometry; the intensity was determined with a Bioanalyzer (Agilent Technologies, Santa Clara, CA, U.S.A.).
Microarray hybridization: We used OpArray Rat genome 27K oligonucleotide microarrays (Operon Biotechnologies GmbH, Cologne, Germany) that consisted of 26,962 oligos, representing about 22,000 rat genes (including expressed sequence tags ESTs). Microarray experiments were performed according to the manufacturer's protocol. For microarray hybridization, total RNA from WB-F344 cells was treated as indicated, pooled (30 g) and labeled with Cyanine 3 (Cy3)-or Cyanine 5 (Cy5)-conjugated dCTP (GE Healthcare; Piscataway, NJ, U.S.A.) in a reverse transcription reaction using a SuperScrip ll reverse transcriptase (Invitrogen). We hybridized three TA-treated sample replicates per time point (1, 3, 6, 12 and 24 hr) . Processed slides were scanned with an Axon 4000B Scanner (Axon, Foster City, CA, U.S.A.) using laser excitation wavelengths of 532 nm (for Cy3) and 635 nm (for Cy5). Scanned images for each slide were analyzed using the GenePix Pro 5.1 software (Axon).
Real 
.).
Data management: The raw intensity data was globally normalized by intensity-dependent normalization using the Lowess method; each print-tip was then normalized by the with-print-tip group normalization method. Each OpArray Rat genome 27K microarray used 48 tips. Statistical software was used to determine means for the triplicate experimental data. Microarray data management was performed with the GeneSpring 7.2 software (Agilent Technologies). All clustering analyses were performed using standard correlations. The fold-change filters used required that "upregulated" genes be present at >200% of the control levels and that "downregulated" genes be present at <50% of the control levels.
RESULTS

Cytotoxicity assay: Upon exposing WB-F344 cells to
concentrations of TA ranging from 0 to 10,000 M, we observed concentration-dependent cytotoxicity. We then determined the concentrations of TA mediating 20% and 50% cell death using an MTT assay. Following 24 hr with TA treatment, we observed 20% and 50% cell death at the 1,000 and 10,000 M concentrations, respectively, and we used these respective concentrations as the low (1,000 M) and high (10,000 M) TA concentrations in our subsequent studies.
Analysis of microarray expression data with hierarchical clustering: In order to identify genes that are transcriptionally regulated by TA in WB-F344 cells, we hybridized the arrays described above with fluorophore-labeled total RNA isolated from untreated or treated cells at 1, 3, 6, 12 or 24 hr following TA exposure. We conducted triplicate hybridizations for each time point. For expression analysis, we considered only those genes that displayed 2-fold up-or downregulation over the untreated levels. Hierarchical clustering was based on the expression profiles of the genes with significant TA-induced variation across all hybridization replicates. We also performed early and late phase hierarchical clustering, subcategorized by each concentration (Fig. 1 ). Individual cells were colored based on the logs of their fluorescence ratios, with black representing a ratio of 1 (no change in expression relative to the initial time point). Increased and decreased expression levels were colored red and green, respectively. We sorted each concentration group into two main clusters based on their differential expression during the early (1 and 3 hr after treatment) and late phases (6, 12 and 24 hr after treatment). We identified a total of 2,129 and 2,348 genes that were modulated by the low and high TA concentrations, respectively. Of these genes, 1,299 were modulated under both low and high concentrations of TA at one or more of the five time points. With regard to the early phases (1 and 3 hr), 1,410 genes were differentially expressed under the low TA concentration and 1,858 genes were differentially expressed under the high concentration (Table 1) . Because of some overlapping gene ontology (GO) groups, the total number of genes is slightly higher in this table. Interestingly, most of differentially-expressed genes were modulated within the timeframe regarded as the early toxicity phases (1 and 3 hr) [20] .
Comparisons between each concentration and phase: To identify specific genes that were altered in a time-dependent manner, we focused on the genes that were differentially expressed at least once during the five time points and looked for overlaps. Table 2 shows the overlapping genes; we identified 25 overlapping genes that were upregulated under a low TA concentration, 28 genes that were upregu- lated under a high TA concentration; 5 genes that were downregulated under a low TA concentration; and 5 genes that were downregulated under a high TA concentration. From these above identified overlapping genes, we omitted the ESTs and unknown genes from further study ( Table 2) . Expression pattern analysis based on time after TA administration: In order to estimate the major gene expression profiles, we performed expression pattern analyses based on the time that elapsed after TA administration. We categorized six groups of genes (A-F) displaying timedependent gene expression, as shown in Fig. 2 . Within the six pattern cluster, the numbers of genes in each pattern were as follows: A, low concentration=375, high concentration=379; B, low concentration=342, high concentration=177; C, low concentration=32, high concentration=111; D, low concentration=80, high concentration=212; E, low concentration=153, high concentration=94; and F, low concentration=8, high concentration=61. Again, since more genes were modulated during the earlier time points, these analyses also indicated that identifying and characterizing genes associated with the early phase of hepatotoxicity might provide important insights into interpreting functional cytotoxicity studies in an in vitro system.
Classification of genes in TA-induced in vitro toxicity: Above, we categorized the genes whose expression changed significantly in each phase of toxicity. Additionally, a few hundred genes from sequential phases were categorized into 12 classes based on GO (Table 1); Figure 3 describes the groups of modulated genes whose gene products were classified as apoptosis regulators, structural proteins or members of a G-protein coupled receptor signaling pathway. Interestingly, the apoptosis and structural protein genes were largely upregulated during the early phases.
Comparison of array results with real-time PCR:
To verify the microarray results, we selected three genes (Rasgrp 1, Rad51 and Trib3) for real-time PCR analysis. At three time points, the q-PCR data from the three genes showed expression trends that were similar to those from the microarray data (Table 3) . In microarray study, the three genes that show up-regulation with time dependent exposure are also expressed in a time dependent manner in q-PCR. Thus comparison of array data between time points is a reasonable method to detect genes that are up-regulated with respect to time following TA administration.
DISCUSSION
Measuring changes in gene expression levels following toxicant exposure provides valuable information about the toxicant's mechanism of action [31] . This information can also be used as a molecular signature to identify the toxicant following exposure. Development of genome-wide microarrays has allowed this technology to become a more powerful tool in toxicogenomics. Several studies have reported the effects of TA on the expression of individual genes in the rat liver [36] and the effects of high concentration TA-administration in rats [15, 25] . In this study, we evaluated cytotoxic low-concentration and high-concentration TA exposure for 1 to 24 hr. The concentration levels of TA were chosen based on the extent of cytotoxicity measured herein and as mentioned in a previous report [11] . We first examined gene expression profiles after in vitro TA treatment using whole genomic microarrays. Although the array contained 22,000 genes, only 12,600 oligonucleotides were classified with a GO term by functional annotation. Hierarchical clustering revealed that the gene expression pattern in the early phases (1 and 3 hr time points) was different from that in the late phases (6, 12 and 24 hr time points; Fig. 1) . We classified the genes into two major representative groups, the early and late phases groups , based on previously-published in vivo reports [26] . The modulated genes were mainly implicated in signal transduction, apoptosis and G-protein receptor pathways. In the early phases, TA strongly induced expression of the Vav1 gene (vav 1 oncogene). This gene product stimulates guanyl nucleotide exchange by a GTPase in the Rho family [13] . We noted upregulation of Arhgef1 (Rho guanine nucleotide exchange factor 1), which induces Vav1 expression through its GTPase activator activity. Interestingly, we observed modulation of several G-protein receptor related genes, including Htr4 (hypoxanthine guanine phosphoribosyl transferase), Calcr (calcitonin receptor), Et1 (endothelin 1), Tacr1 (tachykinin receptor 1), Oprk1 (opioid receptor kappa 1) and Rgs7 (regulator of G-protein signaling 7). In G-protein signaling, Htr4 and Oprk1 have inverse functions involved in adenylate cyclase activation [12] and inhibition pathways. Herein, Htrp4 was upregulated and Oprk1 was downregulated in the early phases, supporting previous studies that suggest these genes might function in concert with opposing reactions. In contrast, the Calcr, Et1, Tacr1 and Rgs7 genes were inhibited during the early phases.
In the early phases, several genes related to apoptosis regulation were upregulated including, Bmf (Bcl2 modifying factor), Fadd (Fas-associated death domain) and Prlr (prolactin receptor) [33] . Functionally, Bmf modifies Bcl2 factors at a crucial checkpoint in initiation of apoptosis. Fadd is an adaptor protein that transmits death signals from lethal receptors of the tumor necrosis factor superfamily [24] . The Bcl2 and Fadd genes are also signaling components in pathways separated from the main apoptosis pathway. The gene expression patterns we observed at 1 and 3 hr after TA treatment support previous descriptions of these pathways (Fig.  1) .
We also determined that the time following TA administration clearly affects the specific expression profile. Several groups of genes were upregulated specifically in the early ( Fig. 2A) or late phases ( Fig. 2B and C) , while other groups were down-regulated in early (Fig. 2D ) or late phases ( Fig. 2E and F) . A few hundred of these genes were functionally categorized as apoptosis regulators, structural proteins, or G-protein coupled receptors (Fig. 3) .
In the early phases, we observed significant upregulation of the apoptosis-related genes Prkcz (Protein kinase C zeta) and Traf2 (Tnf receptor-associated factor 2) for both TA concentrations (Fig. 3A) . Prkcz reportedly functions in cell proliferation signal transduction and cell and tumor promoter activation [25] . Activated Prkcz regulates the JUNcascade signaling pathway in apoptosis, as does Traf2. Interestingly, we also noticed upregulation of several genes encoding apoptosis inhibitors, such as Bmf and Bag3 (Bcl2-associated athanogene 3). Since all of these genes were differentially expressed only in the early phases, we assume that genes related to cytotoxicity are highly regulated in the early toxicity phase, perhaps promoting a compensatory increase in genes within the apoptosis regulator category.
Furthermore, the external signals transmitted through Gprotein coupled receptors (GPCR), which have seven trans- membrane helices, eventually reach the nucleolus; physical translocation of signal molecules is an integral step in membrane-nucleolus linked pathways [25] . Therefore, upregulation of GPCR and Prkcz in the early phases may be part of an essential cell signal transmission pathway that is activated in response to TA treatment (Fig. 3C) . For the most part, genes that were differentially expressed in both the early and late phases encoded cell structure and signal transcription proteins (Fig. 3B) . Arpc (actin related protein 2/3 complex, subunit 5), Myh9 (myosin, heavy polypeptide 9) and Dbn1 (drebrin 1) all function in cell structure and differentiation.
Our analysis of overlapping genes upregulated under high TA concentrations revealed two toxicity-related genes: Txnrd1 (thioredoxin reductase 1) and Cyp1a1 (cytochrome P450, family 1, subfamily a, polypeptide 1). Txnrd1 is oxidative stress indicator and redox-sensitive gene [19] . Cyp1a1 is a monooxygenase that functions in dioxin metabolism [19] and 3-methylcholanthrene-inducible detoxification [28] .
Interestingly, the gene expression patterns reported in a recent TA toxicity study in an in vivo system [26] were quite different from those revealed in our in vitro experiments. For example, the FMO1 gene was downregulated in vivo but did not change in vitro. The in vivo study identified 17 potential hepatotoxicity markers [25] , but our study recapitulated only one of these regulated genes (Txnrd1, NM_031614, thioredoxin reductase 1 mRNA). This discrepancy may be due to differences in the experimental biological systems, such as the use of Sprague Dawley rats (in vivo) versus rat liver epithelial cells (in vitro), the concentrations or the microarrays employed in the respective studies. Most importantly, we used whole genomic microarrays with 22,000 genes, instead of 9,936 genes, to analyze the in vivo expression [26] . Therefore, it is not easy to directly compare the results of these two studies at this stage. Taken as a whole, however, our results clearly suggest that the early responses of genes may directly correlate with the specific mechanism underlying TA-induced cytotoxicity.
